Phase 2 Induction Therapy Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Consolidation ImmunotherapyChemoradiotherapyLimited-stage Small Cell Lung Cancer (LS-SCLC)+1 more
Shanghai Chest Hospital28 enrolled1 locationNCT07091305
Recruiting
Phase 2
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
ImmunotherapyInduction TherapyLocally Advanced Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT07085234
Recruiting
Phase 2
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
ChemotherapyPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University208 enrolled3 locationsNCT06811844
Recruiting
Phase 2
Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Esophageal CancerSurgeryImmunotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled3 locationsNCT06421376